Brief: Sanofi Collaborates With Exscientia To Develop Up To 15 New Drugs

Exscientia

07/01/2022 06:05

Jan 7 (Reuters) - Sanofi  SASY.PA :
    * REG-EXSCIENTIA AND SANOFI ESTABLISH STRATEGIC RESEARCH
COLLABORATION TO DEVELOP AI-DRIVEN PIPELINE OF
PRECISION-ENGINEERED MEDICINES
    * REG-EXSCIENTIA AND SANOFI ESTABLISH STRATEGIC RESEARCH
COLLABORATION TO DEVELOP AI-DRIVEN PIPELINE OF
PRECISION-ENGINEERED MEDICINES
    * EXSCIENTIA AND SANOFI ESTABLISH STRATEGIC RESEARCH
COLLABORATION
TO DEVELOP AI-DRIVEN PIPELINE OF PRECISION-ENGINEERED MEDICINES
    * EXSCIENTIA WILL RECEIVE AN UPFRONT CASH PAYMENT OF $100
MILLION
WITH POTENTIAL OF $5.2 BILLION IN TOTAL MILESTONES PLUS TIERED
ROYALTIES
    * RESEARCH WILL BE FOCUSED ON UP TO 15 NOVEL SMALL MOLECULE
CANDIDATES ACROSS ONCOLOGY AND IMMUNOLOGY
    * THIS UPFRONT CASH PAYMENT OF $100 MILLION IS EXPECTED TO
BE
REFLECTED IN Q1 2022 FINANCIAL RESULTS OF EXSCIENTIA

Source text for Eikon:  urn:newsml:reuters.com:*:nBw9DrT7da
Further company coverage:  SASY.PA 

 ((Reuters.Briefs@thomsonreuters.com;))